Currently available boosters enough to fight Omicron variant: Fauci

White House Chief Medical advisor Antony Fauci on Wednesday said that the currently available booster shots work against the Omicron variant of Covid-19 .

Anthony Fauci
"Our booster vaccine regimens work against omicron," Fauci told the public during a White House Covid update on Wednesday. "At this point, there is no need for a variant-specific booster." | Photo: Reuters
ANI
2 min read Last Updated : Dec 16 2021 | 8:34 AM IST

White House Chief Medical advisor Antony Fauci on Wednesday said that the currently available booster shots work against the Omicron variant of coronavirus (Covid-19) and there is no need for a variant-specific booster.

"Our booster vaccine regimens work against omicron," Fauci told the public during a White House Covid update on Wednesday. "At this point, there is no need for a variant-specific booster."

Fauci said the primary two-dose vaccination series from Pfizer and BioNTech is significantly compromised by omicron, but still offers considerable protection against severe disease, CNBC reported.

Protection from the two-dose vaccine against infection dropped to 33 per cent compared with 80% before the emergence of omicron. However, two doses are still 70 per cent effective at preventing hospitalization in omicron patients in South Africa, Fauci said.

Centres for Disease Control and Prevention Director Rochelle Walensky said at least 36 states in the US and over 75 countries have reported confirmed cases caused by the Omicron variant.

The Omicron variant is now estimated to represent about 3 per cent of the cases in the United States.

In some areas of the country, the director said that the estimates of Omicron are even higher, including in New York and New Jersey where CDC projects that Omicron could represent about 13 per cent of all cases.

"In looking at early data on the transmissibility of Omicron from other countries, we expect to see the proportion of Omicron cases here in the United States continue to grow in the coming weeks," he said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineWhite House

First Published: Dec 16 2021 | 8:34 AM IST

Next Story